|
1
|
Sherer BA and Levine LA: Contemporary
review of treatment options for Peyronie's disease. Urology.
95:16–24. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wynn TA and Ramalingam TR: Mechanisms of
fibrosis: Therapeutic translation for fibrotic disease. Nat Med.
18:1028–1040. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang HS, Zhu LL, Zhang Z, Chen H, Chen Y
and Dai YT: Estradiol attenuates the TGF-β1-induced conversion of
primary TAFs into myofibroblasts and inhibits collagen production
and myofibroblast contraction by modulating the Smad and Rho/ROCK
signaling pathways. Int J Mol Med. 36:801–807. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vernet D, Ferrini MG, Valente EG, Magee
TR, Bou-Gharios G, Rajfer J and Gonzalez-Cadavid NF: Effect of
nitric oxide on the differentiation of fibroblasts into
myofibroblasts in the Peyronie's fibrotic plaque and in its rat
model. Nitric Oxide. 7:262–276. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Magee TR, Qian A, Rajfer J, Sander FC,
Levine LA and Gonzalez-Cadavid NF: Gene expression profiles in the
Peyronie's disease plaque. Urology. 59:451–457. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zorba OU, Sirma S, Ozgon G, Salabas E,
Ozbek U and Kadioglu A: Comparison of apoptotic gene expression
profiles between Peyronie's disease plaque and tunica albuginea.
Adv Clin Exp Med. 21:607–614. 2012.PubMed/NCBI
|
|
7
|
Powell DW, Mifflin RC, Valentich JD, Crowe
SE, Saada JI and West AB: Myofibroblasts. I. Paracrine cells
important in health and disease. Am J Physiol. 277:C1–C9. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gelbard M: Myofibroblasts and
mechanotransduction: Do forces in the tunica albuginea contribute
to Peyronie's disease? J Sex Med. 5:2974–2976. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arno AI, Amini-Nik S, Blit PH, Al-Shehab
M, Belo C, Herer E and Jeschke MG: Effect of Human Wharton's Jelly
Mesenchymal Stem Cell Paracrine Signaling on Keloid Fibroblasts.
Stem Cells Transl Med. 3:299–307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kocher AA, Schlechta B, Gasparovicova A,
Wolner E, Bonaros N and Laufer G: Stem cells and cardiac
regeneration. Transpl Int. 20:731–746. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Salibian AA, Widgerow AD, Abrouk M and
Evans GR: Stem cells in plastic surgery: A review of current
clinical and translational applications. Arch Plast Surg.
40:666–675. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li L, Zhang S, Zhang Y, Yu B, Xu Y and
Guan Z: Paracrine action mediate the antifibrotic effect of
transplanted mesenchymal stem cells in a rat model of global heart
failure. Mol Biol Rep. 36:725–731. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iwamoto T, Terai S, Hisanaga T, Takami T,
Yamamoto N, Watanabe S and Sakaida I: Bone-marrow-derived cells
cultured in serum-free medium reduce liver fibrosis and improve
liver function in carbon-tetrachloride-treated cirrhotic mice. Cell
Tissue Res. 351:487–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gatti S, Bruno S, Deregibus MC, Sordi A,
Cantaluppi V, Tetta C and Camussi G: Microvesicles derived from
human adult mesenchymal stem cells protect against
ischaemia-reperfusion-induced acute and chronic kidney injury.
Nephrol Dial Transplant. 26:1474–1483. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ortiz LA, Gambelli F, McBride C, Gaupp D,
Baddoo M, Kaminski N and Phinney DG: Mesenchymal stem cell
engraftment in lung is enhanced in response to bleomycin exposure
and ameliorates its fibrotic effects. Proc Natl Acad Sci USA.
100:pp. 8407–8411. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou Y, Yuan J, Zhou B, Lee AJ, Lee AJ,
Ghawji M Jr and Yoo TJ: The therapeutic efficacy of human adipose
tissue-derived mesenchymal stem cells on experimental autoimmune
hearing loss in mice. Immunology. 133:133–140. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang WP, Akahoshi T, Piao JS, Narahara S,
Murata M, Kawano T, Hamano N, Ikeda T and Hashizume M: Splenectomy
enhances the therapeutic effect of adipose tissue-derived
mesenchymal stem cell infusion on cirrhosis rats. Liver Int.
36:1151–1159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tzouvelekis A, Paspaliaris V, Koliakos G,
Ntolios P, Bouros E, Oikonomou A, Zissimopoulos A, Boussios N,
Dardzinski B, Gritzalis D, et al: A prospective, non-randomized, no
placebo-controlled, phase Ib clinical trial to study the safety of
the adipose derived stromal cells-stromal vascular fraction in
idiopathic pulmonary fibrosis. J Transl Med. 11:1712013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Burgos-Silva M, Semedo-Kuriki P,
Donizetti-Oliveira C, Costa PB, Cenedeze MA, Hiyane MI,
Pacheco-Silva A and Câmara NO: Adipose Tissue-Derived Stem Cells
Reduce Acute and Chronic Kidney Damage in Mice. PLoS One.
10:e01421832015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yun IS, Jeon YR, Lee WJ, Lee JW, Rah DK,
Tark KC and Lew DH: Effect of human adipose derived stem cells on
scar formation and remodeling in a pig model: A Pilot Study.
Dermatol Surg. 38:1678–1688. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lam MT, Nauta A, Meyer NP, Wu JC and
Longaker MT: Effective delivery of stem cells using an
extracellular matrix patch results in increased cell survival and
proliferation and reduced scarring in skin wound healing. Tissue
Eng Part A. 19:738–747. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lauer-Fields JL, Juska D and Fields GB:
Matrix metalloproteinases and collagen catabolism. Biopolymers.
66:19–32. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schofield AV and Bernard O: Rho-associated
coiled-coil kinase (ROCK) signaling and disease. Crit Rev Biochem
Mol Biol. 48:301–316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiu X, Villalta J, Ferretti L, Fandel TM,
Albersen M, Lin G, Dai Y, Lue TF and Lin CS: Effects of intravenous
injection of adipose-derived stem cells in a rat model of radiation
therapy-induced erectile dysfunction. J Sex Med. 9:1834–1841. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu LL, Zhang Z, Jiang HS, Chen H, Chen Y
and Dai YT: Superparamagnetic iron oxide nanoparticle targeting of
adipose tissue-derived stem cells in diabetes-associated erectile
dysfunction. Asian J Androl. 19:425–432. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ahuja SK, Sikka SC and Hellstrom WJ:
Stimulation of collagen production in an in vitro model for
Peyronie's disease. Int J Impot Res. 11:207–212. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu FX, Su LF, Dai CL, Wang Y, Teng YY, Fu
JH, Zhang QY and Tang YH: Inhibition of pancreatic stellate cell
activity by adipose-derived stem cells. Hepatobiliary Pancreat Dis
Int. 14:215–221. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Woessner JF Jr: The determination of
hydroxyproline in tissue and protein samples containing small
proportions of this imino acid. Arch Biochem Biophys. 93:440–447.
1961. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun Z, Wang C, Shi C, Sun F, Xu X, Qian W,
Nie S and Han X: Activated Wnt signaling induces myofibroblast
differentiation of mesenchymal stem cells, contributing to
pulmonary fibrosis. Int J Mol Med. 33:1097–1109. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu F, Liu C, Zhou D and Zhang L:
TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis. J
Histochem Cytochem. 64:157–167. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Zhang W, Gao J, Liu J, Wang H, Li J,
Yang X, He T, Guan H, Zheng Z, et al: Adipose tissue-derived stem
cells suppress hypertrophic scar fibrosis via the p38/MAPK
signaling pathway. Stem Cell Res Ther. 7:1022016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Harn HJ, Lin SZ, Hung SH, Subeq YM, Li YS,
Syu WS, Ding DC, Lee RP, Hsieh DK, Lin PC and Chiou TW:
Adipose-derived stem cells can abrogate chemical-induced liver
fibrosis and facilitate recovery of liver function. Cell
Transplant. 21:2753–2764. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Q, Liu LN, Yong Q, Deng JC and Cao
WG: Intralesional injection of adipose-derived stem cells reduces
hypertrophic scarring in a rabbit ear model. Stem Cell Res Ther.
6:1452015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hattori H and Ishihara M: Altered protein
secretions during interactions between adipose tissue- or bone
marrow-derived stromal cells and inflammatory cells. Stem Cell Res
Ther. 6:702015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gagliano N, Arosio B, Grizzi F, Masson S,
Tagliabue J, Dioguardi N, Vergani C and Annoni G: Reduced
collagenolytic activity of matrix metalloproteinases and
development of liver fibrosis in the aging rat. Mech Ageing Dev.
123:413–425. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang YR, Wei QX, Wan YG, Sun W, Mao ZM,
Chen HL, Meng XJ, Shi XM, Tu Y and Zhu Q: Ureic clearance granule,
alleviates renal dysfunction and tubulointerstitial fibrosis by
promoting extracellular matrix degradation in renal failure rats,
compared with enalapril. J Ethnopharmacol. 155:1541–1552. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
García-Alvarez J, Ramirez R, Checa M,
Nuttall RK, Sampieri CL, Edwards DR, Selman M and Pardo A: Tissue
inhibitor of metalloproteinase-3 is up-regulated by transforming
growth factor-beta 1 in vitro and expressed in fibroblastic foci in
vivo in idiopathic pulmonary fibrosis. Exp Lung Res. 32:201–214.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fang S, Xu C, Zhang Y, Xue C, Yang C, Bi
H, Qian X, Wu M, Ji K, Zhao Y, et al: Umbilical cord-derived
mesenchymal stem cell-derived exosomal MicroRNAs suppress
myofibroblast differentiation by inhibiting the transforming growth
factor-beta/SMAD2 pathway during wound healing. Stem Cells Transl
Med. 5:1425–1439. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Thumkeo D, Watanabe S and Narumiya S:
Physiological roles of Rho and Rho effectors in mammals. Eur J Cell
Biol. 92:303–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fukata Y, Kimura K, Oshiro N, Saya H,
Matsuura Y and Kaibuchi K: Association of the myosin-binding
subunit of myosin phosphatase and moesin: Dual regulation of moesin
phosphorylation by Rho-associated kinase and myosin phosphatase. J
Cell Biol. 141:409–418. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sopko NA, Hannan JL and Bivalacqua TJ:
Understanding and targeting the Rho kinase pathway in erectile
dysfunction. Nat Rev Urol. 11:622–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kwon KD, Choi MJ, Park JM, Song KM, Kwon
MH, Batbold D, Yin GN, Kim WJ, Ryu JK and Suh JK: Silencing histone
deacetylase 2 using small hairpin RNA induces regression of
fibrotic plaque in a rat model of Peyronie's disease. BJU Int.
114:926–936. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gonzalez-Cadavid NF and Rajfer J:
Mechanisms of disease: New insights into the cellular and molecular
pathology of Peyronie's disease. Nat Clin Pract Urol. 2:291–297.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Golan-Gerstl R, Wallach-Dayan SB, Zisman
P, Cardoso WV, Goldstein RH and Breuer R: Cellular FLICE-like
inhibitory protein deviates myofibroblast fas-induced apoptosis
toward proliferation during lung fibrosis. Am J Respir Cell Mol
Biol. 47:271–279. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rodgers KD, Rao V, Meehan DT, Fager N,
Gotwals P, Ryan ST, Koteliansky V, Nemori R and Cosgrove D:
Monocytes may promote myofibroblast accumulation and apoptosis in
Alport renal fibrosis. Kidney Int. 63:1338–1355. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Horowitz JC, Rogers DS, Sharma V, Vittal
R, White ES, Cui Z and Thannickal VJ: Combinatorial activation of
FAK and AKT by transfonning growth factor-beta1 confers an
anoikis-resistant phenotype to myofibroblasts. Cell Signal.
19:761–771. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Iekushi K, Taniyama Y, Azuma J, Sanada F,
Kusunoki H, Yokoi T, Koibuchi N, Okayama K, Rakugi H and Morishita
R: Hepatocyte growth factor attenuates renal fibrosis through
TGF-β1 suppression by apoptosis of myofibroblasts. J Hypertens.
28:2454–2461. 2010.PubMed/NCBI
|
